SELL and nasopharyngeal carcinoma: Kaplan–Meier analyses found that CCR7, CD22, TNFRSF13C, CR2, SELL, PTPRC, and MS4A1 were advantage prognosticator of OS in NPC, respectively (Fig. S7A-G).